The Big Interview: Franklin Templeton's Gilbey on challenges, opportunities and industry evolution

UK country head

Kathleen Gallagher
clock • 6 min read

Franklin Templeton’s Martyn Gilbey joined the firm from Aberdeen Asset Management (now abrdn) almost five years ago. At the time the move meant that he would be running a business that was ten times smaller, but he felt there was a significant opportunity for growth.

Since then, Franklin Templeton has grown organically as well as through acquisitions. Over the past couple of years Franklin Templeton bought Lexington Partners, O'Shaughnessy Asset Management, the investment grade credit team from Aviva Investors and Legg Mason. More recently the firm announced the acquisition of European credit and private debt specialist, Alcentra.  Now the UK business makes up $19.5bn (£15.4bn) of the firm's global $1.5trn (£1.2trn) assets under management. The CEO of the UK business spoke to Investment Week's features editor Kathleen Gallagher about the integrati...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Companies

Monzo fined £21m by FCA for failings in financial crime controls

Monzo fined £21m by FCA for failings in financial crime controls

Around 34,000 high-risk clients onboarded

Linus Uhlig
clock 08 July 2025 • 2 min read
Citi becomes minority investor in HANetf

Citi becomes minority investor in HANetf

Growing interest in European ETFs

Patrick Brusnahan
clock 03 July 2025 • 2 min read
AstraZeneca CEO mulls moving listing to the US – reports

AstraZeneca CEO mulls moving listing to the US – reports

Latest blow to LSE

Linus Uhlig
clock 02 July 2025 • 1 min read
Trustpilot